Literature DB >> 34779164

[Opioids in primary total joint arthroplasty: Interpretation of 2020 AAHKS/ASRA/AAOS/THS/TKS clinical practice guidelines].

Shuai Zhang1,2,3, Xiangpeng Kong2, Wei Chai2,3.   

Abstract

In 2020, the American Association of Hip and Knee Surgeons (AAHKS), the American Society of Regional Anesthesia and Pain Medicine (ASRA), the American Academy of Orthopaedic Surgeons (AAOS), the American Hip Society (THS), the American Knee Society (TKS) have worked together to develop clinical practice guidelines on the use of Opioids in primary total joint arthroplasty (TJA). This clinical practice guideline formulates recommendations for common and important questions related to the efficacy and safety of Opioids in primary TJA. This article interprets the guideline to help doctors make clinical decisions.

Entities:  

Keywords:  Opioids; multimodal analgesia; total joint arthroplasty

Mesh:

Substances:

Year:  2021        PMID: 34779164      PMCID: PMC8586767          DOI: 10.7507/1002-1892.202103090

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  44 in total

1.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.

Authors:  Steven Kurtz; Kevin Ong; Edmund Lau; Fionna Mowat; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2007-04       Impact factor: 5.284

Review 2.  Multimodal pain management after total joint arthroplasty.

Authors:  Javad Parvizi; Adam G Miller; Kishor Gandhi
Journal:  J Bone Joint Surg Am       Date:  2011-06-01       Impact factor: 5.284

3.  Transdermal fentanyl patch improves post-operative pain relief and promotes early functional recovery in patients undergoing primary total knee arthroplasty: a prospective, randomised, controlled trial.

Authors:  Shigemi Matsumoto; Kazu Matsumoto; Hiroki Iida
Journal:  Arch Orthop Trauma Surg       Date:  2015-06-26       Impact factor: 3.067

Review 4.  Multimodal Analgesia for Total Joint Arthroplasty.

Authors:  Mohamad J Halawi; Stuart A Grant; Michael P Bolognesi
Journal:  Orthopedics       Date:  2015-07-01       Impact factor: 1.390

5.  Impact of Preoperative Opioid Use on Total Knee Arthroplasty Outcomes.

Authors:  Savannah R Smith; Jennifer Bido; Jamie E Collins; Heidi Yang; Jeffrey N Katz; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2017-05-17       Impact factor: 5.284

6.  The James A. Rand Young Investigator's Award: Large Opioid Prescriptions Are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial.

Authors:  Charles P Hannon; Tyler E Calkins; Jefferson Li; Chris Culvern; Brian Darrith; Denis Nam; Tad L Gerlinger; Asokumar Buvanendran; Craig J Della Valle
Journal:  J Arthroplasty       Date:  2019-02-04       Impact factor: 4.757

7.  The 2018 Chitranjan S. Ranawat, MD Award: Developing and Implementing a Novel Institutional Guideline Strategy Reduced Postoperative Opioid Prescribing After TKA and THA.

Authors:  Cody C Wyles; Mario Hevesi; Eleanor R Trousdale; Daniel S Ubl; Halena M Gazelka; Elizabeth B Habermann; Robert T Trousdale; Mark W Pagnano; Tad M Mabry
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

8.  Lack of analgesic effect of 50 and 100 mg oral tramadol after orthopaedic surgery: a randomized, double-blind, placebo and standard active drug comparison.

Authors:  Audun Stubhaug; Jens Grimstad; Harald Breivik
Journal:  Pain       Date:  1995-07       Impact factor: 6.961

9.  A comparison of regularly dosed oral morphine and on-demand intramuscular morphine in the treatment of postsurgical pain.

Authors:  J P McCormack; C B Warriner; M Levine; N Glick
Journal:  Can J Anaesth       Date:  1993-09       Impact factor: 5.063

10.  Transdermal fentanyl patch for postoperative analgesia in total knee arthroplasty: a randomized double-blind controlled trial.

Authors:  Thepakorn Sathitkarnmanee; Sirirat Tribuddharat; Kanlayarat Noiphitak; Sunchai Theerapongpakdee; Sasiwimon Pongjanyakul; Yuwadee Huntula; Maneerat Thananun
Journal:  J Pain Res       Date:  2014-08-01       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.